Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on June 17, 2025
ReversingLabs Named to Inc.’s 2025 Best Workplaces List
GlobeNewswire
·
June 17, 2025
CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- ReversingLabs, the trusted name in file and software security, today announced it has been named to Inc.’s 2025 Best Workplaces list, honoring companies that have built exceptional workplaces and vibrant …
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
GlobeNewswire
·
June 17, 2025
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine Kinase Inhibitor - ALPHARETTA, Ga., June 17, 2025 (GLOBE …
TDG Gold Announces Acquisition of Anyox Copper and C$25 Million Bought Deal Private Placement
GlobeNewswire
·
June 17, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WHITE ROCK, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- TDG Gold Corp (TSXV: TDG, OTCQX:TDGGF) (the “Company” or “TDG”) is pleased to announce that it …
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
GlobeNewswire
·
June 17, 2025
CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has signed a new 10-year commercial …
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
GlobeNewswire
·
June 17, 2025
BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that …
Tisento Therapeutics Receives U.S. FDA Fast Track Designation for Zagociguat for the Treatment of MELAS
GlobeNewswire
·
June 17, 2025
CAMBRIDGE, Mass., June 17, 2025 (GLOBE NEWSWIRE) -- Tisento Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to zagociguat for the treatment of MELAS (Mitochondrial Encephalomyopathy, Lactic …
Microbix Attending & Presenting at Asia Pacific POC 2025
GlobeNewswire
·
June 17, 2025
MISSISSAUGA, Ontario, June 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it is attending and presenting at the 2nd Asia Pacific Conference on …
Next-Gen Edge AI Solutions for the Real World: Autonomous Navigation for Drones, Surveillance and Robotics
GlobeNewswire
·
June 17, 2025
IRVINE, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions enabling Edge AI Intelligence, today announced its collaboration with Aerora, a provider of integrated NDAA-compliant …
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
GlobeNewswire
·
June 17, 2025
REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty …
Aldebaran Reports Infill Drilling Results from Eleven Holes at the Altar Copper-Gold Project in San Juan Argentina
GlobeNewswire
·
June 17, 2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Aldebaran Resources Inc. (“Aldebaran” or the “Company”) (TSX-V: ALDE, OTCQX: ADBRF) is pleased to provide results of 11 holes from the in-fill drilling program currently being completed at the …
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
GlobeNewswire
·
June 17, 2025
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, …
Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone
GlobeNewswire
·
June 17, 2025
MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the final assay results from the Southwest Zone (“Southwest”) as part of its ongoing 2025 Exploration …
Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest
GlobeNewswire
·
June 17, 2025
MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer les résultats d’analyse finaux provenant de la zone Southwest («Southwest») dans le cadre de sa …
Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia
GlobeNewswire
·
June 17, 2025
Highlights Metallurgical testwork program with encouraging preliminary results including 89% average flotation recovery from 120-150µm grind size producing clean concentrate with grade of 20-25% Cu. Pre-concentration and heap leach testwork ongoing with …
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
GlobeNewswire
·
June 17, 2025
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for neurodegenerative diseases VTX3232 …
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
GlobeNewswire
·
June 17, 2025
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of …
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
·
June 17, 2025
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it was …
Material Update on Off-Market Takeover by Bastion Mining
GlobeNewswire
·
June 17, 2025
TORONTO, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) to acquire …
Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project
GlobeNewswire
·
June 17, 2025
Locked cycle tests exceed 90% copper and molybdenum recoveries and confirm clean final products with high separation efficiency Vancouver, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) …
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
GlobeNewswire
·
June 17, 2025
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European Society of Organ Transplantation (ESOT) …